ARCHIVES

DCT Program Cutbacks Planned as Research Stressed In 4 Cancers

This article is from The Cancer Letter archive.

Vol. 19 No. 09 | February 26, 1993

Download PDF Visit The Full Archive

Related Articles

Regulatory Policy: Bush To Seek Legislation For Pediatric Drug Tests.

January 3, 2003

Chi Van Dang Named Director of University Of Pennsylvania Abramson Cancer Center

July 15, 2011

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

September 8, 1978

Proteomics Used To Find Predictor Of Response In FAP

April 30, 2004

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

Copeland Named Director, UF Cancer Center

February 10, 1995